<PAGE>

                                                                   EXHIBIT 10.24

          Summary of Compensation Policy for Directors of Applix, Inc.

The following summarized the compensation policy for directors of Applix, Inc.
(the "Company"):

Cash Compensation

      Employee directors of the Company do not receive compensation for their
services as directors. The non-employee directors receive annual compensation
for their services as directors as follows:

        -   $10,000 to each non-employee director;

        -   an additional $25,000 for the non-employee director serving as the
            Chairman of the Board;

        -   an additional $25,000 for the non-employee director serving as the
            Audit Committee chairman; and

        -   an additional $12,500 for the non-employee director serving as the
            Compensation Committee chairman.

      In addition, non-employee directors are reimbursed for expenses incurred
in connection with attendance at Board of Directors meetings.

Stock Options

      Pursuant to the 2003 Director Equity Plan (the "2003 Director Plan"), (1)
each non-employee director received a stock option for 10,000 shares of common
stock on January 1, 2004, (2) each non-employee director receives a stock option
for 10,000 shares of common stock on January 1 of each year, so long as he or
she continues to serve as a director and provided he or she attended at least
75% of the meetings of the Board of Directors and any committees on which he or
she served in the preceding year and (3) each new non-employee director receives
a stock option to purchase 10,000 shares of common stock upon such director's
initial election to the Board of Directors (an "Election Grant"). All of the
stock options described above have an exercise price equal to the fair market
value of the common stock on the date of grant. Except for Election Grants, the
stock options become exercisable on the first anniversary of the date of grant
(or upon an earlier change in control of the Company), provided the optionee
continues to serve as a director of the Company on such date; and expire seven
years from the date of grant or 90 days after the optionee ceases to serve as a
director. Election Grants become exercisable in two equal annual installments on
the first and second anniversaries of the date of grant (or upon an earlier
change in control of the Company), provided the optionee continues to serve as a
director of the Company on such date.

<PAGE>

Stock Awards

      The non-employee directors automatically receive grants of common stock of
the Company on January 1 of each year as follows:

      -     $5,000 worth of common stock to each non-employee director serving
            as a director on such date;

      -     an additional $10,000 worth of common stock to the non-employee
            director serving as Chairman of the Board of Directors on such date;

      -     an additional $2,500 worth of common stock to each non-employee
            director serving on the Audit Committee on such date;

      -     an additional $5,000 worth of common stock to the non-employee
            director serving as the Chairman of the Audit Committee on such
            date;

      -     an additional $2,500 worth of common stock to each non-employee
            director serving on the Compensation Committee on such date;

      -     an additional $2,500 worth of common stock to the non-employee
            director serving as the Chairman of the Compensation Committee on
            such date; and

      -     an additional $2,500 worth of common stock to each non-employee
            director serving on the Nominating and Corporate Governance
            Committee on such date, provided that such grant shall not be made
            if such non-employee director is also a member of either the
            Compensation Committee or the Audit Committee on such date.

Such common stock shall be valued at the average closing price of the common
stock on The NASDAQ SmallCap Market (or such other principal exchange on which
the common stock is then listed, or the average of the closing bid and asked
prices in the over-the-counter market, as applicable) on the five consecutive
trading days ending two days prior to the date of each grant.